StoryFunding
Junevity closes $10M seed funding led by Goldcrest Capital
Junevity announced $10 million in seed funding from Goldcrest Capital and Godfrey Capital to develop cell reprogramming therapeutics for metabolic and aging diseases.
Junevity announced $10 million in seed funding from Goldcrest Capital and Godfrey Capital to develop cell reprogramming therapeutics for metabolic and aging diseases.